Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-147,600
Closed -$4.46M 4340
2025
Q4
$4.46M Buy
147,600
+67,400
+84% +$1.65M ﹤0.01% 1529
2025
Q3
$1.59M Buy
80,200
+49,200
+159% +$1.03M ﹤0.01% 2287
2025
Q2
$773K Sell
31,000
-11,300
-27% -$255K ﹤0.01% 2895
2025
Q1
$992K Sell
42,300
-118,800
-74% -$3.44M ﹤0.01% 2667
2024
Q4
$4.5M Sell
161,100
-132,100
-45% -$3.54M ﹤0.01% 1729
2024
Q3
$5.98M Sell
293,200
-273,000
-48% -$6.11M 0.01% 1290
2024
Q2
$16.7M Buy
566,200
+59,900
+12% +$1.72M 0.03% 673
2024
Q1
$15.5M Buy
506,300
+383,500
+312% +$10.8M 0.03% 745
2023
Q4
$2.87M Sell
122,800
-23,000
-16% -$556K 0.01% 1761
2023
Q3
$4.32M Buy
+145,800
New +$4.89M 0.01% 1276

Other funds holding CFLT

Squarepoint's CFLT Position: Q1 2026 in Review

Squarepoint sold out of Confluent (CFLT) in Q1 2026, closing a stake of 1,454,703 shares — an estimated $44M sold.

Squarepoint first reported a position in CFLT in Q2 2021 and held it in 12 quarters. The position peaked at $83.2M in Q2 2025. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • Squarepoint reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 1,454,703 Confluent shares in Q1 2026, an estimated $44M.
  • Squarepoint first reported a position in Confluent in Q2 2021 and held it in 12 quarters.
  • Squarepoint's Confluent position peaked at $83.2M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.